In a recent research report by Maximize Market Research, the Tunisia Pharmaceutical Market is expected to surpass US $ 3.4 Bn by the year 2027, from the US $ 1.5 Bn in 2020.
The market is mainly driven by Tunisia’s improved pharmaceutical exports, which are a result of the country’s growing pool of domestic pharmaceutical producers. The government is continuing to seek and capitalize on export markets, particularly in Africa’s Francophone countries. In Sub-Saharan Africa, manufacturers are also involved in on-site production. Teriak, located in Tunisia, for example, purchased Cameroon’s Cinpharm factory in late 2015 to export to Central African markets. Although Tunisian pharmaceutical firms have established themselves in African markets, they face a number of obstacles, including a lack of infrastructure that allows for direct air routes, marine links, and corporate regulations that stifle their expansion across the continent.
Some domestic firms have begun producing pharmaceuticals in West Africa to lower the cost of imports for nations in the area, which has given the Tunisian pharmaceutical industry a substantial boost. Medis, for example, was recognized as the firm that sells to most nations. Eleven nations have partnered with the firm. Teriak, positioned next in the private Tunisia market in 2019, with an increase in exports from 3.5% in 2012 to 14% in 2019.
The injectables segment is projected to dominate the growth of the market in the forecast period. Injectables are delivered via the parenteral route, which is the second most frequent and quickest method of drug administration. Injectables are available from a variety of businesses, including MédiS Laboratories, which specializes in the quick creation of sophisticated medication formulations, primarily injectables. Moreover, the Intravenous route offers quick pharmacokinetic action in the body. Despite a huge decline in the sales of products during the initial phase of pandemic spread and lockdown restrictions all over the region, the market is observed to pick up a quick pace for registering a CAGR of almost more than 12.9 %, during the tenure of 2021 – 2027.
The report published by Maximize encompasses the market dynamics, which could affect the market growth of the Tunisia Pharmaceutical Market in the region, the Value – Chain Analysis, and the PORTER’s analysis for the Tunisia Pharmaceutical Market at a global level. The study is associated based on major segments and further into sub-segments, Formulation (Tablets, Capsules, Injectables, sprays, suspension, powder, other formulation) to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2019, considering 2020 as the base year.
Lastly, the market research report provides a regional comparison and a complete country-level analysis for the Technology trends, along with the major key players- Adwya; Sanofi (Sanofi-Aventis Tunisia); Teriak; Opalia pharma; Les Laboratoires UNIMED; Medis; Taha Pharma; Cytopharma, Novartis, Abbvie, GlaxoSmithKline, Roche, Unimed, IPHAT.,Pierre Fabre, Bayer Schering, Leiras, Orion Farmos, Orion Pharma, Pfizer, and Santen
You can browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on the “Tunisia Pharmaceutical Market.”
https://www.maximizemarketresearch.com/market-report/tunisia-pharmaceutical-market/119566/
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Office no. 18.4,
Navale IT Zone Phase-2,
Mumbai -Bangalore bypass highway,
Pune- 18.411018.41
Maharashtra, India
+91 9607195908